1. Home
  2. Browse Decisions
  3. P.3d
  4. 499 P.3d
  5. 499 P.3d 719 (2021)
 

STATE EX REL. HUNTER v. JOHNSON & JOHNSON

No. 118,474.

499 P.3d 719 (2021)

2021 OK 54

STATE of Oklahoma EX REL. Mike HUNTER, Attorney General of Oklahoma, Plaintiff/Appellee/Counter-Appellant, v. JOHNSON & JOHNSON; Janssen Pharmaceuticals, Inc.; Ortho-McNeil Janssen Pharmaceuticals, Inc., n/k/a Janssen Pharmaceuticals, Inc.; and Janssen Pharmaceutica, Inc., n/k/a Janssen Pharmaceuticals, Inc., Defendants/Appellants/Counter-Appellees, and Purdue Pharma L.P.; Purdue Pharma, Inc.; the Purdue Frederick Company; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Allergan, PLC, f/k/a Actavis, PLC, f/k/a Actavis, Inc., f/k/a Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Actavis LLC; and Actavis Pharma, Inc., f/k/a Watson Pharma, Inc., Defendants.

Supreme Court of Oklahoma.

Filed November 9, 2021.

Attorney(s) appearing for the Case

Mike Hunter , Attorney General for the State of Oklahoma, Abby Dillsaver , General Counsel to the Attorney General, and Ethan A. Shaner , Deputy General Counsel, Oklahoma Office of the Attorney General, Oklahoma City, Oklahoma, for Plaintiff/Appellee/Counter-Appellant.

Michael Burrage , Reggie Whitten , and Randa K. Reeves , Whitten Burrage, Oklahoma City, Oklahoma, for Plaintiff/Appellee/Counter-Appellant.

Bradley E. Beckworth , Lisa Baldwin , and Nathan B. Hall , Nix Patterson, LLP, Oklahoma City, Oklahoma, for Plaintiff/Appellee/Counter-Appellant.

John Thorne , Brendan J. Crimmins , and Ariela M. Migdal , Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C., Washington, D.C., for Plaintiff/Appellee/Counter-Appellant.

Larry D. Ottaway , Amy Sherry Fischer , and Andrew M. Bowman , Foliart, Huff, Ottaway & Bottom, Oklahoma City, Oklahoma, for Defendants/Appellants/Counter-Appellees.

Andrew W. Lester and A.J. Ferate , Spencer Fane LLP, Oklahoma City, Oklahoma, for Defendants/Appellants/Counter-Appellees.

Benjamin H. Odom , John H. Sparks , and Michael W. Ridgeway , Odom & Sparks, PLLC, Norman, Oklahoma, for Defendants/Appellants/Counter-Appellees.

Charles C. Lifland and Jonathan P. Schneller , O'Melveny & Myers, LLP, Los Angeles, California, for Defendants/Appellants/Counter-Appellees.

Stephen D. Brody , O'Melveny & Myers, LLP, Washington, D.C., for Defendants/Appellants/Counter-Appellees.

Jeffrey L. Fisher , O'Melveny & Myers, LLP, Menlo Park, California, for Defendants/Appellants/Counter-Appellees.

¶1 An opioid drug epidemic exists in the United States. Oklahoma has experienced abuse and misuse of opioid medications, opioid use disorder, and thousands of opioid-related deaths in the past two decades. Specifically, opioid-related deaths increased during the early 2000s, plateaued around 2007,

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases